Double-blind, randomized, placebo-controlled, Phase II/III trial on the efficacy and tolerability of treatment with budesonide oral suspension vs. placebo in children and adolescents with eosinophilic esophagitis
Latest Information Update: 10 Mar 2025
At a glance
- Drugs Budesonide (Primary)
- Indications Eosinophilic oesophagitis
- Focus Therapeutic Use
- Acronyms PEDEOS-1
- Sponsors Dr Falk Pharma
Most Recent Events
- 10 Mar 2024 Status changed from recruiting to completed.
- 08 Feb 2024 This trial has been completed in Germany.
- 14 Sep 2023 According to European Clinical Trials Database record, this trial has been completed in Netherlands.